top of page
Abstract Lines

AITHENA took a significant step forward in 2024 by raising seven-figure pre-seed funding to transform compliance solutions in the pharmaceutical sector. With over three decades of expertise in healthcare and pharmaceuticals, AITHENA is supported by experienced tech leaders who have successfully launched and managed multiple publicly traded companies internationally.           

Graph

Pre-seed funding round is closed, but if you are interested in future investment rounds, please register your interest below

bottom of page